A Win For uniQure N.V.
Wed, Jun 17, 2026 at 07:55 PM
uniQure N.V. (QURE:NASDAQ) rocketted at $48.16, representing a gain of 78.4%. On Wed, Jun 17, 2026, QURE:NASDAQ touched a New 2-Week High of $48.16. The stock got featured on our News Catalysts scanner on Wed, Jun 17, 2026 at 05:19 PM in the 'BIOTECH' category. From Wed, Jun 03, 2026, the stock recorded 50.00% Up Days and 63.64% Green Days
About uniQure N.V. (QURE:NASDAQ)
uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.
Top 10 Gainers:
- IceCure Medical Ltd (ICCM:NASDAQ), 200.47%
- Sleep Number Corporation (SNBR:NASDAQ), 120.84%
- Eshallgo Inc. (EHGO:NASDAQ), 118.94%
- Sadot Group Inc. (SDOT:NASDAQ), 98.15%
- J-Star Holding Co. Ltd. (YMAT:NASDAQ), 94.3%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 84.67%
- uniQure N.V. (QURE:NASDAQ), 78.44%
- Fathom Holdings Inc. (FTHM:NASDAQ), 75.36%
- Elicio Therapeutics, Inc. (ELTX:NASDAQ), 70.65%
- AstroNova, Inc. (ALOT:NASDAQ), 69.86%